Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis - PubMed (original) (raw)
Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis
A Nishiyama et al. Mol Biol Cell. 1995 Dec.
Free PMC article
Abstract
NG2 is a chondroitin sulfate proteoglycan that is expressed on dividing progenitor cells of several lineages including glia, muscle, and cartilage. It is an integral membrane proteoglycan with a core glycoprotein of 300 kDa. In the present study we have characterized three molecular forms of the NG2 core protein expressed by different cell lines. Many cell lines that express the full length 300-kDa NG2 core protein also release a 290-kDa form into the medium. This species lacks the cytoplasmic domain but contains almost the entire ectodomain. Two core protein species, the intact 300-kDa form and a truncated 275-kDa form, are expressed at the surface of an NG2-transfected cell line U251NG52. The 275-kDa species lacks the cytoplasmic domain and at least 64 amino acids of the ectodomain. Mild trypsinization of B49 cells also generates the 275-kDa species, suggesting that this component is produced by proteolysis of the 300-kDa form. Conversion of the 300-kDa species to the 275-kDa form in U251NG52 cells is stimulated by reagents such as phorbol esters, which activate protein kinase C. Phorbol esters are also known to induce expression of metalloproteinases such as collagenase and stromelysin, which could be responsible for cleavage of the 300-kDa core protein. Although B49 cells do not spontaneously produce the truncated 275-kDa species, use of monoclonal antibodies against NG2 to block the interaction between NG2 and type VI collagen results in the appearance of the 275-kDa component in these cells. Thus the interaction between NG2 and type VI collagen, which contains a Kunitz-type proteinase inhibitor sequence in the alpha 3 chain, may protect the proteoglycan against proteolysis. This is consistent with the observed deficiency of U251NG52 cells in anchoring type VI collagen at the surface.
Similar articles
- A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen.
Burg MA, Nishiyama A, Stallcup WB. Burg MA, et al. Exp Cell Res. 1997 Aug 25;235(1):254-64. doi: 10.1006/excr.1997.3674. Exp Cell Res. 1997. PMID: 9281375 - Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface.
Nishiyama A, Stallcup WB. Nishiyama A, et al. Mol Biol Cell. 1993 Nov;4(11):1097-108. doi: 10.1091/mbc.4.11.1097. Mol Biol Cell. 1993. PMID: 8305732 Free PMC article. - The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells.
Levine JM, Nishiyama A. Levine JM, et al. Perspect Dev Neurobiol. 1996;3(4):245-59. Perspect Dev Neurobiol. 1996. PMID: 9117258 Review. - The Role of NG2 Proteoglycan in Glioma.
Yadavilli S, Hwang EI, Packer RJ, Nazarian J. Yadavilli S, et al. Transl Oncol. 2016 Feb;9(1):57-63. doi: 10.1016/j.tranon.2015.12.005. Transl Oncol. 2016. PMID: 26947882 Free PMC article. Review.
Cited by
- Estrogen regulation of cell proliferation and distribution of estrogen receptor-alpha in the brains of adult female prairie and meadow voles.
Fowler CD, Johnson F, Wang Z. Fowler CD, et al. J Comp Neurol. 2005 Aug 22;489(2):166-79. doi: 10.1002/cne.20638. J Comp Neurol. 2005. PMID: 15984004 Free PMC article. - The role of the extracellular matrix in angiogenesis in malignant glioma tumors.
Wang D, Anderson JC, Gladson CL. Wang D, et al. Brain Pathol. 2005 Oct;15(4):318-26. doi: 10.1111/j.1750-3639.2005.tb00117.x. Brain Pathol. 2005. PMID: 16389944 Free PMC article. Review. - NG2 Proteoglycan Enhances Brain Tumor Progression by Promoting Beta-1 Integrin Activation in both Cis and Trans Orientations.
Stallcup WB. Stallcup WB. Cancers (Basel). 2017 Mar 31;9(4):31. doi: 10.3390/cancers9040031. Cancers (Basel). 2017. PMID: 28362324 Free PMC article. Review. - TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
Church JS, Kigerl KA, Lerch JK, Popovich PG, McTigue DM. Church JS, et al. J Neurosci. 2016 Jun 8;36(23):6352-64. doi: 10.1523/JNEUROSCI.0353-16.2016. J Neurosci. 2016. PMID: 27277810 Free PMC article. - Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.
Massey JM, Amps J, Viapiano MS, Matthews RT, Wagoner MR, Whitaker CM, Alilain W, Yonkof AL, Khalyfa A, Cooper NG, Silver J, Onifer SM. Massey JM, et al. Exp Neurol. 2008 Feb;209(2):426-45. doi: 10.1016/j.expneurol.2007.03.029. Epub 2007 Apr 12. Exp Neurol. 2008. PMID: 17540369 Free PMC article.
References
- J Cell Biol. 1972 Nov;55(2):390-405 - PubMed
- Nature. 1974 May 17;249(454):224-7 - PubMed
- Med Biol. 1978 Aug;56(4):184-93 - PubMed
- Biochemistry. 1979 Nov 27;18(24):5294-9 - PubMed
- Dev Biol. 1981 Apr 15;83(1):146-53 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases